Andrew Brenner

  • 2167 Citations
  • 23 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrew Brenner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Novel ERbeta agonists for the treatment of gliomas

Vadlamudi, R. K., Brenner, A. J. & Brenner, A.

National Institutes of Health


Project: Research project

  • Research Output

    • 2167 Citations
    • 23 h-Index
    • 54 Article
    • 5 Review article
    • 3 Comment/debate
    • 1 Conference contribution

    A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

    GLOBE Study Investigators , May 15 2020, In : Neuro-oncology. 22, 5, p. 705-717 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    Everolimus inhibits the progression of ductal carcinoma in situ to invasive breast cancer via downregulation of MMP9 expression

    Chen, G., Ding, X. F., Pressley, K., Bouamar, H., Wang, B., Zheng, G., Broome, L. E., Nazarullah, A., Brenner, A. J., Kaklamani, V., Jatoi, I. & Sun, L. Z., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1486-1496 11 p.

    Research output: Contribution to journalArticle

  • PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway

    Luo, Y., Li, M., Pratap, U. P., Viswanadhapalli, S., Liu, J., Venkata, P. P., Altwegg, K. A., Palacios, B. E., Li, X., Chen, Y., Rao, M. K., Brenner, A. J., Sareddy, G. R. & Vadlamudi, R. K., Mar 1 2020, In : Molecular Carcinogenesis. 59, 3, p. 281-292 12 p.

    Research output: Contribution to journalArticle

  • Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

    Hong, D. S., Kang, Y. K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J. L., Kim, T. Y., Shin, S., Becerra, C. R., Falchook, G., Stoudemire, J., Martin, D., Kelnar, K., Peltier, H., Bonato, V., Bader, A. G., Smith, S. & 3 others, Kim, S., O’Neill, V. & Beg, M. S., May 26 2020, In : British Journal of Cancer. 122, 11, p. 1630-1637 8 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study

    Brenner, A. J., Peters, K. B., Vredenburgh, J., Bokstein, F., Blumenthal, D. T., Yust-Katz, S., Peretz, I., Oberman, B., Freedman, L. S., Ellingson, B. M., Cloughesy, T. F., Sher, N., Cohen, Y. C., Lowenton-Spier, N., Rachmilewitz Minei, T., Yakov, N., Mendel, I., Breitbart, E. & Wen, P. Y., May 15 2020, In : Neuro-oncology. 22, 5, p. 694-704 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations